{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:12:11Z","timestamp":1781716331284,"version":"3.54.5"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL146574"],"award-info":[{"award-number":["R01HL146574"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG065345"],"award-info":[{"award-number":["R01AG065345"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS134134"],"award-info":[{"award-number":["R01NS134134"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder marked by the deposition of amyloid-beta (A\u03b2) peptides within the walls of small- and medium-sized cerebral vessels, including arteries and capillaries but rarely veins. This vascular amyloid burden compromises vessel integrity, causes hemorrhages, and contributes to cognitive decline. Efficient A\u03b2 clearance is critical for preventing its pathological accumulation. Thus, understanding the molecular players within the vascular microenvironment is essential. Laminin, a key glycoprotein of the vascular basal lamina (BL), is fundamental to maintaining structural stability of the vessels and regulating interactions among endothelial cells, pericytes, and the extracellular matrix. However, controversial findings exist on how laminin regulates A\u03b2 aggregation and clearance, with both inhibitory and facilitative effects reported. Genetic variations in laminin subunits, their cell-specific expression pattern, and BL remodeling during CAA further complicate this relationship. This review synthesizes current knowledge on vascular A\u03b2 deposition and elimination in CAA, with a particular focus on the critical roles of the BL\/laminin and ApoE in shaping the perivascular microenvironment. First, we introduce A\u03b2 processing relevant to CAA and the mechanisms of A\u03b2 clearance in the CNS. Next, laminin-A\u03b2 interactions and their functions in A\u03b2 clearance are summarized. Thirdly, laminin changes and BL remodeling in CAA are discussed. Finally, we discuss the knowledge gap in the field and fundamental questions that need to be answered in future research. Defining the functions of the BL and ApoE within the pathological context of A\u03b2-rich vasculature may yield new insights into CAA pathogenesis and reveal therapeutic targets to limit vascular amyloid accumulation. Our goal is to provide a concise review on this matter in order to facilitate new hypotheses in the field.<\/jats:p>","DOI":"10.1186\/s12987-025-00734-w","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:46:25Z","timestamp":1765536385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Functions of the basal lamina and ApoE in cerebral amyloid angiopathy"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5410-1154","authenticated-orcid":false,"given":"Alejandra","family":"Juan-Palencia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8020-9696","authenticated-orcid":false,"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"734_CR1","doi-asserted-by":"publisher","first-page":"601320","DOI":"10.3389\/fphys.2020.601320","volume":"11","author":"MD Howe","year":"2020","unstructured":"Howe MD, McCullough LD, Urayama A. The role of basement membranes in cerebral amyloid angiopathy. Front Physiol. 2020;11:601320. https:\/\/doi.org\/10.3389\/fphys.2020.601320.","journal-title":"Front Physiol"},{"key":"734_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1750-3639.2006.tb00560.x","volume":"16","author":"MC Herzig","year":"2006","unstructured":"Herzig MC, Van Nostrand WE, Jucker M. Mechanism of cerebral \u03b2-Amyloid angiopathy: murine and cellular models. Brain Pathol. 2006;16:40\u201354. https:\/\/doi.org\/10.1111\/j.1750-3639.2006.tb00560.x.","journal-title":"Brain Pathol"},{"key":"734_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-020-00219-y","volume":"17","author":"M Damodarasamy","year":"2020","unstructured":"Damodarasamy M, Vernon RB, Pathan JL, Keene CD, Day AJ, Banks WA, et al. The microvascular extracellular matrix in brains with alzheimer\u2019s disease neuropathologic change (ADNC) and cerebral amyloid angiopathy (CAA). Fluids Barriers CNS. 2020;17:60. https:\/\/doi.org\/10.1186\/s12987-020-00219-y.","journal-title":"Fluids Barriers CNS"},{"key":"734_CR4","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/brain\/awt188","volume":"136","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National alzheimer\u2019s coordinating centre. Brain. 2013;136:2697\u2013706. https:\/\/doi.org\/10.1093\/brain\/awt188.","journal-title":"Brain"},{"key":"734_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.neurobiolaging.2004.02.003","volume":"25","author":"JAR Nicoll","year":"2004","unstructured":"Nicoll JAR, Yamada M, Frackowiak J, Mazur-Kolecka B, Weller RO. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of alzheimer\u2019s disease. Neurobiol Aging. 2004;25:589\u201397. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.02.003.","journal-title":"Neurobiol Aging"},{"key":"734_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, et al. Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25:270\u20136. https:\/\/doi.org\/10.1038\/s41591-018-0297-y.","journal-title":"Nat Med"},{"key":"734_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350. https:\/\/doi.org\/10.1038\/nrneurol.2017.188.","journal-title":"Nat Rev Neurol"},{"key":"734_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00429-009-0221-9","volume":"214","author":"HJ Garringer","year":"2010","unstructured":"Garringer HJ, Murrell J, D\u2019Adamio L, Ghetti B, Vidal R. Modeling Familial British and Danish dementia. Brain Struct Funct. 2010;214:235\u201344. https:\/\/doi.org\/10.1007\/s00429-009-0221-9.","journal-title":"Brain Struct Funct"},{"key":"734_CR9","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/ijms10041872","volume":"10","author":"S Kumar-Singh","year":"2009","unstructured":"Kumar-Singh S. Hereditary and sporadic forms of A\u03b2-Cerebrovascular amyloidosis and relevant Transgenic mouse models. Int J Mol Sci. 2009;10:1872\u201395. https:\/\/doi.org\/10.3390\/ijms10041872.","journal-title":"Int J Mol Sci"},{"key":"734_CR10","doi-asserted-by":"publisher","first-page":"120866","DOI":"10.1016\/j.jns.2023.120866","volume":"454","author":"M Cozza","year":"2023","unstructured":"Cozza M, Amadori L, Boccardi V. Exploring cerebral amyloid angiopathy: insights into pathogenesis, diagnosis, and treatment. J Neurol Sci Neth. 2023;454:120866. https:\/\/doi.org\/10.1016\/j.jns.2023.120866.","journal-title":"J Neurol Sci Neth"},{"key":"734_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR, Ghebremedhin E, R\u00fcb U, Yamaguchi H, Del Tredici K, Braak H. Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2002;61:282\u201393. https:\/\/doi.org\/10.1093\/jnen\/61.3.282.","journal-title":"J Neuropathol Exp Neurol"},{"key":"734_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1515\/bmc-2014-0041","volume":"6","author":"KV Nguyen","year":"2015","unstructured":"Nguyen KV. The human \u03b2-amyloid precursor protein: biomolecular and epigenetic aspects. Biomol Concepts De Gruyter. 2015;6:11\u201332. https:\/\/doi.org\/10.1515\/bmc-2014-0041.","journal-title":"Biomol Concepts De Gruyter"},{"key":"734_CR13","doi-asserted-by":"publisher","unstructured":"Hasegawa K, Ozawa D, Ookoshi T, Naiki H. Surface-bound basement membrane components accelerate amyloid-\u03b2 peptide nucleation in air-free wells: an in vitro model of cerebral amyloid angiopathy. Biochim Biophys Acta. 2013;1834(8):1624\u201331. https:\/\/doi.org\/10.1016\/j.bbapap.2013.04.011","DOI":"10.1016\/j.bbapap.2013.04.011"},{"key":"734_CR14","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.bbadis.2015.08.025","volume":"1862","author":"J Zekonyte","year":"2016","unstructured":"Zekonyte J, Sakai K, Nicoll JAR, Weller RO, Carare RO. Quantification of molecular interactions between ApoE, amyloid-beta (A\u03b2) and laminin: relevance to accumulation of A\u03b2 in alzheimer\u2019s disease. Biochim Biophys Acta. 2016;1862:1047\u201353. https:\/\/doi.org\/10.1016\/j.bbadis.2015.08.025.","journal-title":"Biochim Biophys Acta"},{"key":"734_CR15","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell RD, Sagare A, Friedman AE, Bedi G, Holtzman DM, Deane R, et al. Transport pathways for clearance of human alzheimer\u2019s amyloid \u03b2-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2007;27:909\u201318. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600419.","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"734_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1590\/s0100-879x2001000500006","volume":"34","author":"C Morgan","year":"2001","unstructured":"Morgan C, Inestrosa NC. Interactions of laminin with the amyloid beta peptide. Implications for alzheimer\u2019s disease. Braz J Med Biol Res Rev Bras Pesqui Medicas E Biol. 2001;34:597\u2013601. https:\/\/doi.org\/10.1590\/s0100-879x2001000500006.","journal-title":"Braz J Med Biol Res Rev Bras Pesqui Medicas E Biol"},{"issue":"2000110162","key":"734_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/1097-4547","volume":"62","author":"GM Castillo","year":"2000","unstructured":"Castillo GM, Lukito W, Peskind E, Raskind M, Kirschner DA, Yee AG, et al. Laminin Inhibition of \u03b2-amyloid protein (A\u03b2) fibrillogenesis and identification of an A\u03b2 binding site localized to the globular domain repeats on the laminin a chain. J Neurosci Res. 2000;62(2000110162):451\u201362. https:\/\/doi.org\/10.1002\/1097-4547. 3%253C451::AID-JNR15%253E3.0.CO;2-F.","journal-title":"J Neurosci Res"},{"key":"734_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1046\/j.1471-4159.1999.0730742.x","volume":"73","author":"B Drouet","year":"1999","unstructured":"Drouet B, Raymond MP, Chambaz J, Pillot T. Laminin 1 attenuates \u03b2-Amyloid peptide A\u03b2(1\u201340) neurotoxicity of cultured fetal rat cortical neurons. J Neurochem. 1999;73:742\u20139. https:\/\/doi.org\/10.1046\/j.1471-4159.1999.0730742.x.","journal-title":"J Neurochem"},{"key":"734_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biochi.2020.04.011","volume":"174","author":"S Rodin","year":"2020","unstructured":"Rodin S, Kozin SA, Kechko OI, Mitkevich VA, Makarov AA. Aberrant interactions between amyloid-beta and alpha5 laminins as possible driver of neuronal Disfunction in alzheimer\u2019s disease. Biochimie. 2020;174:44\u20138. https:\/\/doi.org\/10.1016\/j.biochi.2020.04.011.","journal-title":"Biochimie"},{"key":"734_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13024-021-00502-y","volume":"16","author":"B Nguyen","year":"2021","unstructured":"Nguyen B, Bix G, Yao Y. Basal lamina changes in neurodegenerative disorders. Mol Neurodegener. 2021;16:81. https:\/\/doi.org\/10.1186\/s13024-021-00502-y.","journal-title":"Mol Neurodegener"},{"key":"734_CR21","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.1038\/srep05556","volume":"4","author":"DC Dias","year":"2014","unstructured":"Dias DC, Jovanovic B, Gonsalves K, Moodley D, Reusch K, Knackmuss U. The 37\u00a0kDa\/67\u00a0kDa laminin receptor acts as a receptor for A\u03b242 internalization. Sci Rep. 2014;4:5556. https:\/\/doi.org\/10.1038\/srep05556.","journal-title":"Sci Rep"},{"key":"734_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1440-1789.2005.00631.x","volume":"25","author":"M Maat-Schieman","year":"2005","unstructured":"Maat-Schieman M, Roos R, van Duinen S. Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Neuropathol Off J Jpn Soc Neuropathol Australia. 2005;25:288\u201397. https:\/\/doi.org\/10.1111\/j.1440-1789.2005.00631.x.","journal-title":"Neuropathol Off J Jpn Soc Neuropathol Australia"},{"key":"734_CR23","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1038\/emboj.2010.211","volume":"29","author":"I Kuperstein","year":"2010","unstructured":"Kuperstein I, Broersen K, Benilova I, Rozenski J, Jonckheere W, Debulpaep M, et al. Neurotoxicity of alzheimer\u2019s disease A\u03b2 peptides is induced by small changes in the A\u03b242 to A\u03b240 ratio. EMBO J. 2010;29:3408\u201320. https:\/\/doi.org\/10.1038\/emboj.2010.211.","journal-title":"EMBO J"},{"key":"734_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","volume":"47","author":"E McGowan","year":"2005","unstructured":"McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, et al. A\u03b242 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005;47:191\u20139. https:\/\/doi.org\/10.1016\/j.neuron.2005.06.030.","journal-title":"Neuron"},{"key":"734_CR25","doi-asserted-by":"publisher","unstructured":"Natt\u00e9 R, Yamaguchi H, Maat-Schieman ML, et al. Ultrastructural evidence of early non-fibrillar Abeta42 in the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type. Acta Neuropathol. 1999;98(6):577\u201382. https:\/\/doi.org\/10.1007\/s004010051121","DOI":"10.1007\/s004010051121"},{"key":"734_CR26","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.3390\/biomedicines11102663","volume":"11","author":"M Zedde","year":"2023","unstructured":"Zedde M, Grisendi I, Assenza F, Vandelli G, Napoli M, Moratti C, et al. The venular side of cerebral amyloid angiopathy: proof of concept of a neglected issue. Biomedicines. 2023;11:2663. https:\/\/doi.org\/10.3390\/biomedicines11102663.","journal-title":"Biomedicines"},{"key":"734_CR27","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold K-H, Mistl C, Rothacher S, et al. Two amyloid precursor protein Transgenic mouse models with alzheimer disease-like pathology. Proc Natl Acad Sci U S A. 1997;94:13287\u201392. https:\/\/doi.org\/10.1073\/pnas.94.24.13287.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"734_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0006-8993(99)01361-x","volume":"828","author":"R Natt\u00e9","year":"1999","unstructured":"Natt\u00e9 R, de Boer WI, Maat-Schieman ML, Baelde HJ, Vinters HV, Roos RA, et al. Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls. Brain Res. 1999;828:179\u201383. https:\/\/doi.org\/10.1016\/s0006-8993(99)01361-x.","journal-title":"Brain Res"},{"key":"734_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12551-023-01052-x","volume":"15","author":"VA Petrushanko IYu, Mitkevich","year":"2023","unstructured":"Petrushanko IYu, Mitkevich VA, Makarov AA. Effect of \u03b2-amyloid on blood-brain barrier properties and function. Biophys Rev. 2023;15:183\u201397. https:\/\/doi.org\/10.1007\/s12551-023-01052-x.","journal-title":"Biophys Rev"},{"key":"734_CR30","first-page":"219","volume":"149","author":"K Fukuchi","year":"1996","unstructured":"Fukuchi K, Ho L, Younkin SG, Kunkel DD, Ogburn CE, LeBoeuf RC, et al. High levels of Circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in Transgenic mice. Am J Pathol. 1996;149:219\u201327.","journal-title":"Am J Pathol"},{"key":"734_CR31","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nn1302","volume":"7","author":"MC Herzig","year":"2004","unstructured":"Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD, et al. A\u03b2 is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci Nat Publishing Group. 2004;7:954\u201360. https:\/\/doi.org\/10.1038\/nn1302.","journal-title":"Nat Neurosci Nat Publishing Group"},{"key":"734_CR32","doi-asserted-by":"publisher","first-page":"20296","DOI":"10.1074\/jbc.M312946200","volume":"279","author":"J Davis","year":"2004","unstructured":"Davis J, Xu F, Deane R, Romanov G, Previti ML, Zeigler K, et al. Early-onset and robust cerebral microvascular accumulation of amyloid \u03b2-Protein in Transgenic mice expressing low levels of a vasculotropic Dutch\/Iowa mutant form of amyloid \u03b2-Protein precursor. J Biol Chem Elsevier. 2004;279:20296\u2013306. https:\/\/doi.org\/10.1074\/jbc.M312946200.","journal-title":"J Biol Chem Elsevier"},{"key":"734_CR33","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1074\/jbc.274.10.6483","volume":"274","author":"D Moechars","year":"1999","unstructured":"Moechars D, Dewachter I, Lorent K, Revers\u00e9 D, Baekelandt V, Naidu A, et al. Early phenotypic changes in Transgenic mice that overexpress different mutants of amyloid precursor protein in Brain*. J Biol Chem. 1999;274:6483\u201392. https:\/\/doi.org\/10.1074\/jbc.274.10.6483.","journal-title":"J Biol Chem"},{"key":"734_CR34","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1523\/JNEUROSCI.20-17-06452.2000","volume":"20","author":"I Dewachter","year":"2000","unstructured":"Dewachter I, Van Dorpe J, Smeijers L, Gilis M, Kuip\u00e9ri C, Laenen I, et al. Aging increased amyloid peptide and caused amyloid plaques in brain of old APP\/V717I Transgenic mice by a different mechanism than mutant Presenilin1. J Neurosci. 2000;20:6452\u20138. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-17-06452.2000.","journal-title":"J Neurosci"},{"key":"734_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neurobiolaging.2004.12.007","volume":"27","author":"A Lord","year":"2006","unstructured":"Lord A, Kalimo H, Eckman C, Zhang X-Q, Lannfelt L, Nilsson LNG. The Arctic alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in Transgenic mice. Neurobiol Aging. 2006;27:67\u201377. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.12.007.","journal-title":"Neurobiol Aging"},{"key":"734_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1749-6632.2000.tb06915.x","volume":"920","author":"C Sturchler-Pierrat","year":"2000","unstructured":"Sturchler-Pierrat C, Staufenbiel M. Pathogenic mechanisms of alzheimer\u2019s disease analyzed in the APP23 Transgenic mouse model. Ann N Y Acad Sci. 2000;920:134\u20139. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06915.x.","journal-title":"Ann N Y Acad Sci"},{"key":"734_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in Transgenic mice. Science. 1996;274:99\u2013102. https:\/\/doi.org\/10.1126\/science.274.5284.99.","journal-title":"Science"},{"key":"734_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games D, Adams D, Alessandrini R, Barbour R, Borthelette P, Blackwell C, et al. Alzheimer-type neuropathology in Transgenic mice overexpressing V717F \u03b2-amyloid precursor protein. Nat Nat Publishing Group. 1995;373:523\u20137. https:\/\/doi.org\/10.1038\/373523a0.","journal-title":"Nat Nat Publishing Group"},{"key":"734_CR39","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/nm1123","volume":"10","author":"IH Cheng","year":"2004","unstructured":"Cheng IH, Palop JJ, Esposito LA, Bien-Ly N, Yan F, Mucke L. Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation. Nat Med. 2004;10:1190\u20132. https:\/\/doi.org\/10.1038\/nm1123.","journal-title":"Nat Med"},{"key":"734_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00401-011-0834-y","volume":"122","author":"M Merlini","year":"2011","unstructured":"Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM. Vascular \u03b2-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in Transgenic arcA\u03b2 mice. Acta Neuropathol (Berl). 2011;122:293\u2013311. https:\/\/doi.org\/10.1007\/s00401-011-0834-y.","journal-title":"Acta Neuropathol (Berl)"},{"key":"734_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1750-3639.2008.00164.x","volume":"19","author":"R Vidal","year":"2009","unstructured":"Vidal R, Barbeito AG, Miravalle L, Ghetti B. Cerebral amyloid angiopathy and parenchymal amyloid deposition in Transgenic mice expressing the Danish mutant form of human BRI2. Brain Pathol Zurich Switz. 2009;19:58\u201368. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00164.x.","journal-title":"Brain Pathol Zurich Switz"},{"key":"734_CR42","doi-asserted-by":"publisher","first-page":"7969","DOI":"10.1073\/pnas.1001056107","volume":"107","author":"J Coomaraswamy","year":"2010","unstructured":"Coomaraswamy J, Kilger E, W\u00f6lfing H, Sch\u00e4fer C, Kaeser SA, Wegenast-Braun BM, et al. Modeling Familial Danish dementia in mice supports the concept of the amyloid hypothesis of alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2010;107:7969\u201374. https:\/\/doi.org\/10.1073\/pnas.1001056107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"734_CR43","doi-asserted-by":"publisher","first-page":"1180237","DOI":"10.3389\/fnins.2023.1180237","volume":"17","author":"F Lui","year":"2023","unstructured":"Lui F, Alcaide J, Knowlton S, Ysit M, Zhong N. Pathogenesis of cerebral amyloid angiopathy caused by chaotic glymphatics-Mini-review. Front Neurosci Switz. 2023;17:1180237. https:\/\/doi.org\/10.3389\/fnins.2023.1180237.","journal-title":"Front Neurosci Switz"},{"key":"734_CR44","doi-asserted-by":"publisher","first-page":"107557","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107557","volume":"33","author":"PS Ang","year":"2024","unstructured":"Ang PS, Zhang DM, Azizi S-A, Norton de Matos SA, Brorson JR. The glymphatic system and cerebral small vessel disease. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc United States. 2024;33:107557. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2024.107557.","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc United States"},{"key":"734_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00018-024-05277-1","volume":"81","author":"SJ van Veluw","year":"2024","unstructured":"van Veluw SJ, Benveniste H, Bakker ENTP, Carare RO, Greenberg SM, Iliff JJ, et al. Is CAA a perivascular brain clearance disease? A discussion of the evidence to date and outlook for future studies. Cell Mol Life Sci CMLS Switz. 2024;81:239. https:\/\/doi.org\/10.1007\/s00018-024-05277-1.","journal-title":"Cell Mol Life Sci CMLS Switz"},{"key":"734_CR46","doi-asserted-by":"publisher","first-page":"e00535","DOI":"10.1016\/j.neurot.2025.e00535","volume":"22","author":"O Bonnar","year":"2025","unstructured":"Bonnar O, Eyre B, van Veluw SJ. Perivascular brain clearance as a therapeutic target in cerebral amyloid angiopathy and alzheimer\u2019s disease. Neurotherapeutics. 2025;22:e00535. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00535.","journal-title":"Neurotherapeutics"},{"key":"734_CR47","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in alzheimer\u2019s disease. Science. 2010;330:1774. https:\/\/doi.org\/10.1126\/science.1197623.","journal-title":"Science"},{"key":"734_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-015-1477-1","volume":"130","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Bu X-L, Liu Y-H, Zhu C, Shen L-L, Jiao S-S, et al. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for alzheimer\u2019s disease. Acta Neuropathol (Berl). 2015;130:487\u201399. https:\/\/doi.org\/10.1007\/s00401-015-1477-1.","journal-title":"Acta Neuropathol (Berl)"},{"key":"734_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12987-025-00648-7","volume":"22","author":"A Singh","year":"2025","unstructured":"Singh A, Kaakinen M, Elamaa H, Kiviniemi V, Eklund L. The glycosaminoglycan chains of Perlecan regulate the perivascular fluid transport. Fluids Barriers CNS. 2025;22:48. https:\/\/doi.org\/10.1186\/s12987-025-00648-7.","journal-title":"Fluids Barriers CNS"},{"key":"734_CR50","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s004010050935","volume":"96","author":"WW Zhang","year":"1998","unstructured":"Zhang WW, Lempessi H, Olsson Y. Amyloid angiopathy of the human brain: immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells. Acta Neuropathol (Berl). 1998;96:558\u201363. https:\/\/doi.org\/10.1007\/s004010050935.","journal-title":"Acta Neuropathol (Berl)"},{"key":"734_CR51","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00401-011-0801-7","volume":"121","author":"CA Hawkes","year":"2011","unstructured":"Hawkes CA, H\u00e4rtig W, Kacza J, Schliebs R, Weller RO, Nicoll JA, et al. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol (Berl). 2011;121:431\u201343. https:\/\/doi.org\/10.1007\/s00401-011-0801-7.","journal-title":"Acta Neuropathol (Berl)"},{"key":"734_CR52","doi-asserted-by":"publisher","first-page":"12101","DOI":"10.1002\/chem.202000782","volume":"26","author":"J Ma","year":"2020","unstructured":"Ma J, Ma C, Li J, Sun Y, Ye F, Liu K, et al. Extracellular matrix proteins involved in alzheimer\u2019s disease. Chem Weinh Bergstr Ger Ger. 2020;26:12101\u201310. https:\/\/doi.org\/10.1002\/chem.202000782.","journal-title":"Chem Weinh Bergstr Ger Ger"},{"key":"734_CR53","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2015.08.024","volume":"1862","author":"A Keable","year":"2016","unstructured":"Keable A, Fenna K, Yuen HM, Johnston DA, Smyth NR, Smith C, et al. Deposition of amyloid \u03b2 in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochim Biophys Acta. 2016;1862:1037\u201346. https:\/\/doi.org\/10.1016\/j.bbadis.2015.08.024.","journal-title":"Biochim Biophys Acta"},{"key":"734_CR54","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00401-018-1862-7","volume":"136","author":"NJ Albargothy","year":"2018","unstructured":"Albargothy NJ, Johnston DA, MacGregor-Sharp M, Weller RO, Verma A, Hawkes CA, et al. Convective influx\/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways. Acta Neuropathol (Berl). 2018;136:139\u201352. https:\/\/doi.org\/10.1007\/s00401-018-1862-7.","journal-title":"Acta Neuropathol (Berl)"},{"key":"734_CR55","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/acel.12045","volume":"12","author":"CA Hawkes","year":"2013","unstructured":"Hawkes CA, Gatherer M, Sharp MM, Dorr A, Yuen HM, Kalaria R, et al. Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-\u03b2 from the mouse brain. Aging Cell. 2013;12:224\u201336. https:\/\/doi.org\/10.1111\/acel.12045.","journal-title":"Aging Cell"},{"key":"734_CR56","doi-asserted-by":"publisher","first-page":"123504","DOI":"10.1016\/j.biomaterials.2025.123504","volume":"324","author":"M Jang","year":"2026","unstructured":"Jang M, Lee H-J, Seo EU, Kim HN. Extracellular matrix glycation epigenetically regulates brain aging and neurodegeneration in the in vitro aged neurovascular model. Biomaterials. 2026;324:123504. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123504.","journal-title":"Biomaterials"},{"key":"734_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1296455","author":"M Chmelova","year":"2023","unstructured":"Chmelova M, Androvic P, Kirdajova D, Tureckova J, Kriska J, Valihrach L, et al. A view of the genetic and proteomic profile of extracellular matrix molecules in aging and stroke. Front Cell Neurosci [Internet] Front. 2023. https:\/\/doi.org\/10.3389\/fncel.2023.1296455. [cited 2025 Oct 14];17.","journal-title":"Front Cell Neurosci [Internet] Front"},{"key":"734_CR58","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Xu H, Bu G. ApoE and A\u03b2 in alzheimer\u2019s disease: accidental encounters or partners? Neuron. 2014;81:740\u201354. https:\/\/doi.org\/10.1016\/j.neuron.2014.01.045.","journal-title":"Neuron"},{"key":"734_CR59","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1074\/jbc.M112.442103","volume":"288","author":"LM Tai","year":"2013","unstructured":"Tai LM, Bilousova T, Jungbauer L, Roeske SK, Youmans KL, Yu C, et al. Levels of soluble Apolipoprotein E\/Amyloid-\u03b2 (A\u03b2) complex are reduced and oligomeric A\u03b2 increased with APOE4 and alzheimer disease in a Transgenic mouse model and human Samples\u2666. J Biol Chem. 2013;288:5914\u201326. https:\/\/doi.org\/10.1074\/jbc.M112.442103.","journal-title":"J Biol Chem"},{"key":"734_CR60","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/pathophysiology31040040","volume":"31","author":"A Laslo","year":"2024","unstructured":"Laslo A, Laslo L, Arb\u0103na\u0219i E-M, Ujlaki-Nagi A-A, Chinezu L, Iv\u0103nescu AD, et al. Pathways to alzheimer\u2019s disease: the intersecting roles of clusterin and Apolipoprotein E in Amyloid-\u03b2 regulation and neuronal health. Pathophysiol Off J Int Soc Pathophysiol Switz. 2024;31:545\u201358. https:\/\/doi.org\/10.3390\/pathophysiology31040040.","journal-title":"Pathophysiol Off J Int Soc Pathophysiol Switz"},{"key":"734_CR61","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","volume":"29","author":"KR Bales","year":"2009","unstructured":"Bales KR, Liu F, Wu S, Lin S, Koger D, DeLong C, et al. Human APOE Isoform-Dependent effects on brain \u03b2-Amyloid levels in PDAPP Transgenic mice. J Neurosci. 2009;29:6771\u20139. https:\/\/doi.org\/10.1523\/JNEUROSCI.0887-09.2009.","journal-title":"J Neurosci"},{"key":"734_CR62","doi-asserted-by":"publisher","first-page":"e41636","DOI":"10.1371\/journal.pone.0041636","volume":"7","author":"CA Hawkes","year":"2012","unstructured":"Hawkes CA, Sullivan PM, Hands S, Weller RO, Nicoll JAR, Carare RO. Disruption of arterial perivascular drainage of Amyloid-\u03b2 from the brains of mice expressing the human APOE \u03b54 allele. PLoS ONE. 2012;7:e41636. https:\/\/doi.org\/10.1371\/journal.pone.0041636.","journal-title":"PLoS ONE"},{"key":"734_CR63","doi-asserted-by":"publisher","first-page":"17655","DOI":"10.1038\/s41598-024-67885-y","volume":"14","author":"NG Smets","year":"2024","unstructured":"Smets NG, van der Panne SA, Strijkers GJ, Bakker ENTP. Perivascular spaces around arteries exceed perivenous spaces in the mouse brain. Sci Rep Nat Publishing Group. 2024;14:17655. https:\/\/doi.org\/10.1038\/s41598-024-67885-y.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"734_CR64","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.4103\/1673-5374.335829","volume":"17","author":"Y-L Zhang","year":"2022","unstructured":"Zhang Y-L, Wang J, Zhang Z-N, Su Q, Guo J-H. The relationship between amyloid-beta and brain capillary endothelial cells in alzheimer\u2019s disease. Neural Regen Res India. 2022;17:2355\u201363. https:\/\/doi.org\/10.4103\/1673-5374.335829.","journal-title":"Neural Regen Res India"},{"key":"734_CR65","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","volume":"13","author":"Q Ma","year":"2018","unstructured":"Ma Q, Zhao Z, Sagare AP, Wu Y, Wang M, Owens NC, et al. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-\u03b242 by LRP1-dependent Apolipoprotein E isoform-specific mechanism. Mol Neurodegener. 2018;13:57. https:\/\/doi.org\/10.1186\/s13024-018-0286-0.","journal-title":"Mol Neurodegener"},{"key":"734_CR66","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fnagi.2015.00136","volume":"7","author":"A Ramanathan","year":"2015","unstructured":"Ramanathan A, Nelson AR, Sagare AP, Zlokovic BV. Impaired vascular-mediated clearance of brain amyloid beta in alzheimer\u2019s disease: the role, regulation and restoration of LRP1. Front Aging Neurosci. 2015;7:136. https:\/\/doi.org\/10.3389\/fnagi.2015.00136.","journal-title":"Front Aging Neurosci"},{"key":"734_CR67","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ana.24270","volume":"76","author":"KF Roberts","year":"2014","unstructured":"Roberts KF, Elbert DL, Kasten TP, Patterson BW, Sigurdson WC, Connors RE, et al. Amyloid-\u03b2 efflux from the CNS into the plasma. Ann Neurol. 2014;76:837\u201344. https:\/\/doi.org\/10.1002\/ana.24270.","journal-title":"Ann Neurol"},{"key":"734_CR68","doi-asserted-by":"publisher","unstructured":"Storck SE, Meister S, Nahrath J, Mei\u00dfner JN, Schubert N, Di Spiezio A, et al. Endothelial LRP1 transports amyloid-\u03b21\u201342 across the blood-brain barrier. J Clin Invest. 126:123\u201336. https:\/\/doi.org\/10.1172\/JCI81108","DOI":"10.1172\/JCI81108"},{"key":"734_CR69","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of alzheimer\u2019s amyloid-\u03b21\u201340 peptide from brain by LDL receptor\u2013related protein-1 at the blood-brain barrier. J Clin Invest. 2000;106:1489\u201399. https:\/\/doi.org\/10.1172\/JCI10498.","journal-title":"J Clin Invest"},{"key":"734_CR70","doi-asserted-by":"publisher","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","volume":"2","author":"T Saido","year":"2012","unstructured":"Saido T, Leissring MA. Proteolytic degradation of amyloid \u03b2-Protein. Cold Spring Harb Perspect Med. 2012;2:a006379. https:\/\/doi.org\/10.1101\/cshperspect.a006379.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"734_CR71","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","volume":"40","author":"MA Leissring","year":"2003","unstructured":"Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, et al. Enhanced proteolysis of \u03b2-Amyloid in APP Transgenic mice prevents plaque Formation, secondary Pathology, and premature death. Neuron. 2003;40:1087\u201393. https:\/\/doi.org\/10.1016\/S0896-6273(03)00787-6.","journal-title":"Neuron"},{"key":"734_CR72","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/S0140-6736(03)13555-6","volume":"361","author":"S Tsubuki","year":"2003","unstructured":"Tsubuki S, Takai Y, Saido TC, Dutch. Flemish, Italian, and Arctic mutations of APP and resistance of A\u03b2 to physiologically relevant proteolytic degradation. Lancet Elsevier. 2003;361:1957\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(03)13555-6.","journal-title":"Lancet Elsevier"},{"key":"734_CR73","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5607\/en23014","volume":"32","author":"R Ullah","year":"2023","unstructured":"Ullah R, Lee EJ. Advances in Amyloid-\u03b2 clearance in the brain and periphery: implications for neurodegenerative diseases. Exp Neurobiol. 2023;32:216\u201346. https:\/\/doi.org\/10.5607\/en23014.","journal-title":"Exp Neurobiol"},{"key":"734_CR74","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.14336\/AD.2023.0907","volume":"15","author":"Q Deng","year":"2024","unstructured":"Deng Q, Wu C, Parker E, Liu TC-Y, Duan R, Yang L. Microglia and astrocytes in alzheimer\u2019s disease: significance and summary of recent advances. Aging Dis. 2024;15:1537\u201364. https:\/\/doi.org\/10.14336\/AD.2023.0907.","journal-title":"Aging Dis"},{"key":"734_CR75","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1177\/0271678X221113027","volume":"42","author":"A Nirwane","year":"2022","unstructured":"Nirwane A, Yao Y. Cell-specific expression and function of laminin at the neurovascular unit. J Cereb Blood Flow Metab. 2022;42:1979\u201399. https:\/\/doi.org\/10.1177\/0271678X221113027.","journal-title":"J Cereb Blood Flow Metab"},{"key":"734_CR76","doi-asserted-by":"crossref","unstructured":"Nasrollahi A, Yao Y. Laminins and the blood-brain barrier. Matrix Biol. Elsevier. 2025.","DOI":"10.1016\/j.matbio.2025.02.005"},{"key":"734_CR77","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00018-016-2381-0","volume":"74","author":"Y Yao","year":"2017","unstructured":"Yao Y. Laminin: loss-of-function studies. Cell Mol Life Sci CMLS Switz. 2017;74:1095\u2013115. https:\/\/doi.org\/10.1007\/s00018-016-2381-0.","journal-title":"Cell Mol Life Sci CMLS Switz"},{"key":"734_CR78","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/svn-2018-000198","volume":"4","author":"L Xu","year":"2019","unstructured":"Xu L, Nirwane A, Yao Y. Basement membrane and blood-brain barrier. Stroke Vasc Neurol Engl. 2019;4:78\u201382. https:\/\/doi.org\/10.1136\/svn-2018-000198.","journal-title":"Stroke Vasc Neurol Engl"},{"key":"734_CR79","doi-asserted-by":"publisher","first-page":"10150","DOI":"10.1073\/pnas.90.21.10150","volume":"90","author":"MC Kibbey","year":"1993","unstructured":"Kibbey MC, Jucker M, Weeks BS, Neve RL, Van Nostrand WE, Kleinman HK. beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proc Natl Acad Sci U S A. 1993;90:10150\u20133. https:\/\/doi.org\/10.1073\/pnas.90.21.10150.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"734_CR80","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1038\/ncomms4413","volume":"5","author":"Y Yao","year":"2014","unstructured":"Yao Y, Chen Z-L, Norris EH, Strickland S. Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun. 2014;5:3413. https:\/\/doi.org\/10.1038\/ncomms4413.","journal-title":"Nat Commun"},{"key":"734_CR81","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12975-019-00709-8","volume":"11","author":"J Gautam","year":"2020","unstructured":"Gautam J, Cao Y, Yao Y. Pericytic laminin maintains Blood-Brain barrier integrity in an Age-Dependent manner. Transl Stroke Res. 2020;11:228\u201342. https:\/\/doi.org\/10.1007\/s12975-019-00709-8.","journal-title":"Transl Stroke Res"},{"key":"734_CR82","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s12975-019-0688-5","volume":"10","author":"J Gautam","year":"2019","unstructured":"Gautam J, Miner JH, Yao Y. Loss of endothelial laminin \u03b15 exacerbates hemorrhagic brain injury. Transl Stroke Res. 2019;10:705\u201318. https:\/\/doi.org\/10.1007\/s12975-019-0688-5.","journal-title":"Transl Stroke Res"},{"key":"734_CR83","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40478-019-0676-8","volume":"7","author":"A Nirwane","year":"2019","unstructured":"Nirwane A, Johnson J, Nguyen B, Miner JH, Yao Y. Mural cell-derived laminin-\u03b15 plays a detrimental role in ischemic stroke. Acta Neuropathol Commun. 2019;7:23. https:\/\/doi.org\/10.1186\/s40478-019-0676-8.","journal-title":"Acta Neuropathol Commun"},{"key":"734_CR84","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12987-024-00521-z","volume":"21","author":"A Nirwane","year":"2024","unstructured":"Nirwane A, Kang M, Adithan A, Maharaj V, Nguyen F, Santaella Aguilar E, et al. Endothelial and mural laminin-\u03b15 contributes to neurovascular integrity maintenance. Fluids Barriers CNS. 2024;21:18. https:\/\/doi.org\/10.1186\/s12987-024-00521-z.","journal-title":"Fluids Barriers CNS"},{"key":"734_CR85","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","volume":"68","author":"RD Bell","year":"2010","unstructured":"Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 2010;68:409\u201327. https:\/\/doi.org\/10.1016\/j.neuron.2010.09.043.","journal-title":"Neuron"},{"key":"734_CR86","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","volume":"36","author":"MR Halliday","year":"2016","unstructured":"Halliday MR, Rege SV, Ma Q, Zhao Z, Miller CA, Winkler EA, et al. Accelerated pericyte degeneration and blood-brain barrier breakdown in Apolipoprotein E4 carriers with alzheimer\u2019s disease. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2016;36:216\u201327. https:\/\/doi.org\/10.1038\/jcbfm.2015.44.","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"734_CR87","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296\u2013302. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.032.","journal-title":"Neuron"},{"key":"734_CR88","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41593-019-0434-z","volume":"22","author":"AM Nikolakopoulou","year":"2019","unstructured":"Nikolakopoulou AM, Montagne A, Kisler K, Dai Z, Wang Y, Huuskonen MT, et al. Pericyte loss leads to circulatory failure and Pleiotrophin depletion causing neuron loss. Nat Neurosci. 2019;22:1089\u201398. https:\/\/doi.org\/10.1038\/s41593-019-0434-z.","journal-title":"Nat Neurosci"},{"key":"734_CR89","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11011-021-00814-4","volume":"37","author":"R Ap\u00e1tiga-P\u00e9rez","year":"2022","unstructured":"Ap\u00e1tiga-P\u00e9rez R, Soto-Rojas LO, Campa-C\u00f3rdoba BB, Luna-Viramontes NI, Cuevas E, Villanueva-Fierro I, et al. Neurovascular dysfunction and vascular amyloid accumulation as early events in alzheimer\u2019s disease. Metab Brain Dis United States. 2022;37:39\u201350. https:\/\/doi.org\/10.1007\/s11011-021-00814-4.","journal-title":"Metab Brain Dis United States"},{"key":"734_CR90","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1083\/jcb.201212032","volume":"202","author":"Z-L Chen","year":"2013","unstructured":"Chen Z-L, Yao Y, Norris EH, Kruyer A, Jno-Charles O, Akhmerov A, et al. Ablation of astrocytic laminin impairs vascular smooth muscle cell function and leads to hemorrhagic stroke. J Cell Biol. 2013;202:381\u201395. https:\/\/doi.org\/10.1083\/jcb.201212032.","journal-title":"J Cell Biol"},{"key":"734_CR91","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00018-014-1732-y","volume":"72","author":"Y Yao","year":"2015","unstructured":"Yao Y, Norris EH, Strickland S. The cellular origin of laminin determines its role in blood pressure regulation. Cell Mol Life Sci CMLS. 2015;72:999\u20131008. https:\/\/doi.org\/10.1007\/s00018-014-1732-y.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"734_CR92","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1471-4159.2005.03539.x","volume":"96","author":"SS Mok","year":"2006","unstructured":"Mok SS, Losic D, Barrow CJ, Turner BJ, Masters CL, Martin LL, et al. The \u03b2-amyloid peptide of alzheimer\u2019s disease decreases adhesion of vascular smooth muscle cells to the basement membrane. J Neurochem. 2006;96:53\u201364. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03539.x.","journal-title":"J Neurochem"},{"key":"734_CR93","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1042\/CS20170004","volume":"131","author":"F Held","year":"2017","unstructured":"Held F, Morris AWJ, Pirici D, Niklass S, Sharp MMG, Garz C, et al. Vascular basement membrane alterations and \u03b2-amyloid accumulations in an animal model of cerebral small vessel disease. Clin Sci. 2017;131:1001\u201313. https:\/\/doi.org\/10.1042\/CS20170004.","journal-title":"Clin Sci"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00734-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00734-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00734-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:27:35Z","timestamp":1781627255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-025-00734-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["734"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00734-w","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}